4//SEC Filing
Donenberg Phillip B. 4
Accession 0001209191-22-038691
CIK 0001806310other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:40 PM ET
Size
5.5 KB
Accession
0001209191-22-038691
Insider Transaction Report
Form 4
DONENBERG PHILIP B
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 totalExercise: $2.81Exp: 2032-06-17→ Common Stock (15,500 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001238120
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:40 PM ET
- Size
- 5.5 KB